· Updated · Venture Capital Tracker · investment-strategies · 3 min read
Cleveland Startups and VC Firms in 2026: Clinic Spinouts, JumpStart, Diagnostics
Cleveland venture map in 2026 — Cleveland Diagnostics, Centerline Biomedical, AxoNeural, JumpStart, and ARCH as national biotech company-building capital.
Cleveland’s venture story is Cleveland Clinic and healthcare innovation — diagnostics (IsoPSA), endovascular navigation (Centerline), nanoparticle therapeutics (AxoNeural) — with JumpStart as the local formation engine and ARCH as the national biotech company-building reference.
This page maps what we profile.
City hub: /vc/cleveland · All cities: /cities · Fund directory: /directory
What Cleveland is (and is not)
| Cleveland is… | Cleveland is not… |
|---|---|
| A Clinic / healthcare innovation commercialization metro | Columbus insurtech or Cincinnati CPG tech |
| JumpStart as nonprofit + Ventures pre-seed/seed | A coastal biotech GP wall like Boston |
| Active diagnostics and medtech spinouts we link | A full census of every Clinic company |
Startups we cover in Cleveland
| Company | What they do | Stage / status | Notable capital | Profile |
|---|---|---|---|---|
| Cleveland Diagnostics | Cancer diagnostics company commercializing IsoPSA and the IsoClear protein-structure platform. | Growth | HQ: 3615 Superior Avenue, Cleveland, OH | /startup/cleveland-diagnostics |
| Centerline Biomedical | Cleveland Clinic spinout of IOPS — non-X-ray 3D endovascular surgical navigation. | Growth | Cleveland Clinic spinoff | /startup/centerline-biomedical |
| AxoNeural Therapeutics | Cleveland Clinic spinout developing nanoparticle-delivered therapeutics for neurodegenerative injury. | Seed | Cleveland Clinic spin-off (founded ~2020) | /startup/axoneural-therapeutics |
Why these names matter
Cleveland Diagnostics — Cleveland Clinic–adjacent diagnostics builder HQ’d on Superior Avenue — IsoPSA aims to reduce unnecessary prostate biopsies.
Centerline Biomedical — Clinic commercialization path: Intra-Operative Positioning System (IOPS) to improve endovascular outcomes and cut radiation exposure.
AxoNeural Therapeutics — Clinic nanomedicine translation — Neupron antioxidant enzyme delivery for acute spinal cord injury; Cleveland HQ.
Local investors (Cleveland HQ or program)
| Firm | Role | Stages | Profile |
|---|---|---|---|
| JumpStart | Cleveland nonprofit entrepreneur support + JumpStart Ventures investing arm | Pre-Seed, Seed | /fund/jumpstart-inc |
How to read this: JumpStart is formation capital. ARCH is not Cleveland HQ (Chicago) — we curate it because Clinic-class science companies still meet ARCH-style biotech builders nationally.
National capital Cleveland founders still need
Local funds rarely replace a coastal or specialist Series A. Pitch these directory firms by thesis, not geography:
| Firm | Why founders care | Profile |
|---|---|---|
| ARCH Venture Partners | Biotech company-building from research (Chicago HQ — curated for thesis) | /fund/arch-venture-partners |
| F-Prime Capital | Healthtech / life sciences | /fund/f-prime-capital |
| Define Ventures | Digital health / health-system software | /fund/define-ventures |
| Andreessen Horowitz | Bio + Health when science/metrics clear | /fund/andreessen-horowitz |
| General Catalyst | Multi-stage health | /fund/general-catalyst |
JumpStart seed vs national biotech — what differs
| JumpStart | National biotech / health VC | |
|---|---|---|
| Best for | Pre-seed/seed, Clinic/university spinouts | Clinical-stage syndicates and company-building |
| Check shape | Nonprofit + Ventures checks | ARCH / F-Prime–class priced rounds |
| Underwrite | Northeast Ohio healthcare adjacency | Science milestones + ownership math |
| Mistake | Treating ARCH as a Cleveland GP HQ | Pitching national biotech with zero Clinic/clinical proof |
Worked example (illustrative)
Setup: A Cleveland Clinic spinout raises JumpStart pre-seed and completes key validation studies in Northeast Ohio.
Move: They raise a national biotech Series A (ARCH / F-Prime class) after a clear clinical or diagnostic milestone.
Punch: JumpStart bought time and local density; the science syndicate was national.
When Cleveland is the wrong capital market
- You need Root/Drive Capital insurtech — use /vc/columbus-oh.
- You treat ARCH as Cleveland-headquartered — it is Chicago in our data.
- You invent a full Clinic portfolio census we have not shipped.
- You pitch digital-health SaaS funds for a pure therapeutics asset without translation.
How to use this page
- Read Cleveland Diagnostics, Centerline, AxoNeural.
- Local: JumpStart.
- National biotech: ARCH + health rows above.
- Live hub: /vc/cleveland.
Related reading
Sources
- Startup profiles: cleveland-diagnostics, centerline-biomedical, axoneural-therapeutics
- Fund profiles: jumpstart-inc, arch-venture-partners
- cleveland
- ohio
- venture-capital
- +3 more
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
